Post-implantation clinical cost analysis between transcutaneous and percutaneous bone conduction devices.

ABSTRACT:

Introduction

Bone conduction devices (BCD) are effective for hearing rehabilitation in patients with conductive and mixed hearing loss or single-sided deafness. Transcutaneous bone conduction devices (tBCD) seem to lead to fewer soft tissue complications than percutaneous BCDs (pBCD) but have other drawbacks such as MRI incompatibility and higher costs. Previous cost analyses have shown a cost advantage of tBCDs. The purpose of this study is to compare long-term post-implantations costs between percutaneous and transcutaneous BCDs.

Materials and methods

Retrospective data from 77 patients implanted in a tertiary referral centre with a pBCD (n = 34), tBCD (n = 43; passive (t_pasBCD; n = 34) and active (t_actBCD; n = 9) and a reference group who underwent c

SUBMITTER: Aukema TW 

PROVIDER: S-EPMC10764476 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature